Company Quick10K Filing
Immunomedics
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-31 Filed 2020-02-27
10-Q 2019-09-30 Filed 2019-10-30
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-09
10-Q 2018-09-30 Filed 2018-11-07
10-K 2018-06-30 Filed 2018-08-23
10-Q 2018-03-31 Filed 2018-05-09
10-Q 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-11-09
10-K 2017-06-30 Filed 2017-08-16
10-Q 2017-03-31 Filed 2017-05-10
10-Q 2016-12-31 Filed 2017-02-09
10-Q 2016-09-30 Filed 2016-11-02
10-K 2016-06-30 Filed 2016-08-18
10-Q 2016-03-31 Filed 2016-05-04
10-Q 2015-12-31 Filed 2016-02-03
10-Q 2015-09-30 Filed 2015-11-04
10-K 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-06
10-Q 2014-12-31 Filed 2015-02-04
10-Q 2014-09-30 Filed 2014-11-05
10-K 2014-06-30 Filed 2014-08-25
10-Q 2014-03-31 Filed 2014-05-07
10-Q 2013-12-31 Filed 2014-02-10
10-Q 2013-09-30 Filed 2013-11-04
10-K 2013-06-30 Filed 2013-08-22
10-Q 2013-03-31 Filed 2013-05-08
10-Q 2012-12-31 Filed 2013-02-07
10-K 2012-06-30 Filed 2012-08-23
10-Q 2012-03-31 Filed 2012-05-08
10-Q 2011-12-31 Filed 2012-02-08
10-Q 2011-09-30 Filed 2011-11-04
10-K 2011-06-30 Filed 2011-08-24
10-Q 2011-03-31 Filed 2011-05-10
10-Q 2010-12-31 Filed 2011-02-04
10-Q 2010-09-30 Filed 2010-11-04
10-K 2010-06-30 Filed 2010-08-26
10-Q 2010-03-31 Filed 2010-05-10
10-Q 2009-12-31 Filed 2010-02-02
8-K 2020-07-06 Other Events, Exhibits
8-K 2020-06-18
8-K 2020-05-27
8-K 2020-05-06
8-K 2020-05-05
8-K 2020-04-27
8-K 2020-04-22
8-K 2020-04-06
8-K 2020-04-06
8-K 2020-03-25
8-K 2020-02-27
8-K 2020-02-26
8-K 2020-02-13
8-K 2019-12-26
8-K 2019-12-04
8-K 2019-12-03
8-K 2019-10-30
8-K 2019-09-28
8-K 2019-08-07
8-K 2019-06-05
8-K 2019-05-28
8-K 2019-05-09
8-K 2019-04-29
8-K 2019-04-24
8-K 2019-04-15
8-K 2019-04-15
8-K 2019-04-05
8-K 2019-03-29
8-K 2019-03-13
8-K 2019-03-05
8-K 2019-03-05
8-K 2019-02-22
8-K 2019-02-11
8-K 2019-02-04
8-K 2019-01-17
8-K 2019-01-15
8-K 2018-12-20
8-K 2018-12-19
8-K 2018-12-14
8-K 2018-11-07
8-K 2018-10-02
8-K 2018-09-24
8-K 2018-09-11
8-K 2018-08-23
8-K 2018-08-23
8-K 2018-07-18
8-K 2018-07-06
8-K 2018-06-22
8-K 2018-06-12
8-K 2018-06-04
8-K 2018-06-01
8-K 2018-05-09
8-K 2018-04-13
8-K 2018-04-09
8-K 2018-04-04
8-K 2018-04-02
8-K 2018-02-08
8-K 2018-01-07

Immunomedics Financials

IMMU Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Neogen (NEOG) 3,449 46% 38.2 8% 751 60 422 196 61 89 3,383
Immunomedics (IMMU) 2,749 -8.6 -78% 412 388 0 0 -322 -278 2,383
Quidel (QDEL) 2,603 60% 22.6 9% 868 333 515 308 75 114 2,574
Myriad Genetics (MYGN) 2,118 0% 31.0 -1% 1,591 517 835 0 -15 73 2,255
Lantheus Holdings (LNTH) 1,051 51% 28.3 3% 402 301 344 174 13 41 1,170
Intellia Therapeutics (NTLA) 669 80% -7.3 -26% 347 71 40 32 -90 -86 631
Quotient (QTNT) 549 45% -6.7 -58% 177 224 31 14 -103 -92 621
Oxford Immunotec Global (OXFD) 463 72% -196.4 -0% 239 24 56 40 -0 -1 279
Meridian Bioscience (VIVO) 418 59% 9.9 7% 325 135 201 118 24 43 432
Volitionrx (VNRX) 242 0% -18.8 -53% 24 6 0 0 -13 -12 225
Trinity Biotech (TRIB) 235 0% 152 108 0 0 0 0 228
Oncocyte (OCX) 107 -6.1 -44% 33 3 0 0 -14 -14 87
Nymox Pharmaceutical (NYMX) 92 0% 8 1 0 0 0 0 92
Vermillion (VRML) 51 21% -3.2 -72% 17 5 3 1 -12 -12 37
Immucell (ICCC) 48 49% 62.0 -3% 39 10 10 5 -1 1 47
Riot Blockchain (RIOT) 42 20% -1.6 -50% 33 5 6 1 -17 -16 26
Celldex Therapeutics (CLDX) 40 0% 17.3 0% 132 30 4 0 0 1 23
Achieve Life Sciences (ACHV) 17 -0.6 -147% 11 3 0 0 -17 -17 10
Navidea Biopharmaceuticals (NAVB) 13 99% -1.3 -170% 5 5 1 1 -8 -8 10
Arca Biopharma (ABIO) 9 0.2 -43% 10 1 0 0 -4 -4 -1

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash2116393326214841352721423221106100867662513346155140140359639582439429366
Accounts Receivable1111111101111110001111000000
Inventory11000111111111111000011100
PP&E3332822229222292223033333443567114719353533
Assets2953463931275448413326473827112106928268574153163153156380664613485478412
Accounts Payable11235525
Long-Term Debt
Liabilities677767101174671110106110110113112114113184221220139308264273303363388
Stockholders' Equity23463932252044373429213927175-4-18-31-44-57-72-131-59-67177340134418311624
Income Statement ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Revenue13011112151111112111111111000000
Cost of Revenue00000
Gross Profit10000
R&D56777787778109121012131413131512121725292838585369
SG&A12221222232342222222111155492519211418
Tax00-0-000-000-00000000-3-200000
Net Income-521-7-8-7-58-8-4-9-10-12-12-11-12-12-15-14-14-16-16-59-53-119-3-36-117-64-87-76-94
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash Operating-6-421-6-7-412-6-7-8-9-9-10-11-9-13-8-14-13-17-21-43-32-38-50-55-12-63
Cash Investing-0-0-0-00-0-0-0-20-0-1988-72312111212121417242019-2-4-1
Cash Financing0020-0-01501030-0-09620-0-03-06452543230260